52 results on '"Poolman, Jan"'
Search Results
2. Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections
3. Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial
4. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro
5. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
6. Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models
7. Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells
8. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials
9. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens
10. Neisseria meningitidis serogroup B lipooligosaccharide genotyping reveals high prevalence of L2 strains in Spain and unexpected relationship with factor H-binding protein expression
11. Reply to the letter by Dr. Stanley Plotkin
12. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides
13. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae
14. Induction of Bordetella pertussis-specific immune memory by DTPa vaccines
15. Abrogation of nontypeable Haemophilus influenzae Protein D function reduces phosphorylcholine decoration, adherence to airway epithelial cells, and fitness in a chinchilla model of otitis media
16. Glycoconjugate vaccines and immune interference: A review
17. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age
18. Corrigendum to “Immunogenicity, reactogenicity and persistence of meningococcal A, C,W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years” [Vaccine 27 (2009) 161–168]
19. Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children
20. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics
21. Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years
22. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model
23. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants
24. ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media
25. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
26. Kinetics of the immune response following pneumococcal PD conjugate vaccination
27. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region
28. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study
29. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model
30. Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses
31. Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned
32. Alternative vaccine strategies to prevent serogroup B meningococcal diseases
33. Clinical relevance of lower Hib response in DTPa-based combination vaccines
34. Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys
35. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice
36. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines1All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1
37. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response
38. Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis
39. On the Interaction between a Bactericidal Antibody and a PorA Epitope ofNeisseria meningitidisin Outer Membrane Vesicles: A Competitive Fluorescence Polarization Immunoassay
40. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
41. Molecular characterization of the structural gene for the lactoferrin receptor of the meningococcal strain H44/76.
42. Non-specific modulation of the immune response with liposomal meningococcal lipopolysaccharide: role of different cells and cytokines
43. The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis
44. Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharide
45. The influence of the adjuvant quil a on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies
46. Pneumococcal conjugate vaccines
47. Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens
48. Solid-phase synthesis and applications of N-(S-acetylmercaptoacetyl) peptides
49. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell Elisa
50. The development of an inhibition enzyme-linked immunosorbent assay to detect total antibody to the P1.16 subtype antigen of Neisseria meningitidis in human sera
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.